Sanofi Divests 16 Brands From European Consumer Healthcare Portfolio
28 6월 2021 - 3:47PM
Dow Jones News
By Kim Richters
Sanofi SA said Monday that it has agreed to sell some brands
from its consumer healthcare portfolio in Europe to STADA
Arzneimittel AG in an effort to streamline the section.
The French pharmaceutical company said the agreement covers
registrations, trademarks and related commercial rights for 16
products in Europe.
Sanofi said it doesn't expect its European staff to be affected
on account of the deal, which it assumes will close in the third
quarter of this year.
In a separate release, Germany-based STADA said the deal
includes products like the cough remedies Silomat and the skincare
range Viscontour. It said most of the portfolio's annual turnover
was currently generated in Germany, France, Spain, Italy and
Poland.
The companies didn't disclose financial terms of the
agreement.
Write to Kim Richters at kim.richters@wsj.com
(END) Dow Jones Newswires
June 28, 2021 02:35 ET (06:35 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
Stada Arzneimi Namen (CE) (USOTC:STDAF)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
Stada Arzneimi Namen (CE) (USOTC:STDAF)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024
Stada Arzneimi Namen (CE) (OTC 시장)의 실시간 뉴스: 최근 기사 0
More Stada Arzneimi Namen (PK) News Articles